Search Within

Center for Pancreatic Cancer Research

Formats
  1. Journal Article (5057)
  2. Meeting Abstract (2483)
  3. Book Section (225)
  4. Review (220)
  5. Editorial (135)
  6. Conference Paper (75)
  7. Correspondence (48)
  8. Research Letter (43)
  9. Miscellaneous (41)
  10. Guidelines (38)
  11. Book Whole (20)
Groups
  1. Department of Medicine (3942)
  2. Solid Tumor Oncology Division (3242)
  3. Surgery (3165)
  4. GSK Faculty (2910)
  5. Epidemiology and Biostatistics (2524)
  6. Gastrointestinal Oncology Service (2297)

More Groups

People
  1. Mithat Gonen (1034)
  2. William Jarnagin (911)
  3. Eileen O'Reilly (795)
  4. Michael D'Angelica (787)
  5. T Peter Kingham (620)
  6. David Kelsen (538)

More People

Years
  1. 2025 (286)
  2. 2024 (497)
  3. 2023 (523)
  4. 2022 (602)
  5. 2021 (555)
  6. 2020 (562)

More Years

Publications
  1. Journal of Clinical Oncology (927)
  2. Annals of Surgical Oncology (395)
  3. Cancer Research (226)
  4. International Journal of Radiation Oncology, Biology, Physics (219)
  5. Laboratory Investigation (209)
  6. Modern Pathology (191)

More Publications

Publishers
  1. American Society of Clinical Oncology (1002)
  2. Springer (840)
  3. Elsevier Inc. (757)
  4. Nature Publishing Group (632)
  5. American Association for Cancer Research (551)
  6. Elsevier Science, Inc. (510)

More Publishers

Results (8385)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Kinetics of CA19-9 decline in a randomized phase III study of irinotecan liposome injection, oxaliplatin, 5-fluorouracial/leucovorin (NALIRIFOX) or nab-paclitaxel plus gemcitabine (GEM + NABP) in patients who have not previously received chemotherapy for metastatic adenocarcinoma of the pancreas (NAPOLI 3)
    Meeting Abstract

    Chandana, S. R.; Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R. A.; De La Fouchardiere, C.; Dean, A. P.; Kiss, I.; Lee, W. J.; Goetze, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Inter-reader variability of imaging biomarkers for therapeutic response in pancreatic ductal adenocarcinoma
    Meeting Abstract

    Heiselman, J. S.; Horvat, N.; Agridag-Upcinar, B.; Yildirim, O.; Ecker, B. L.; O'Reilly, E. M.; Drebin, J. A.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Survival of patients with microsatellite instability-high and Lynch syndrome-associated pancreatic ductal adenocarcinomas
    Meeting Abstract

    Nasar, N.; Eikenboom, E.; Seier, K.; Gonen, M.; Wagner, A.; Jarnagin, W. R.; Drebin, J. A.; D'Angelica, M. I.; Kingham, T. P.; Balachandran, V. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers
    Meeting Abstract

    O'Reilly, E. M.; Bauer, T. M.; Borazanci, E. H.; Pelster, M.; Varghese, A. M.; Park, W.; Patel, M. R.; Jameson, G. S.; Larsen, M.; Chin, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Postoperative complications following neoadjuvant therapy and surgery in a phase 2 borderline resectable pancreatic cancer clinical trial (alliance A021501)
    Meeting Abstract

    Snyder, R. A.; Zemla, T. J.; Shi, Q.; Segovia, D. I.; Ahmad, S.; O'Reilly, E. M.; Herman, J. M.; Katz, M. H. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • ARC-8: Phase 1/1b randomized study of quemliclustat + gemcitabine/nab-paclitaxel ± zimberelimab in patients with treatment-naive metastatic pancreatic adenocarcinoma
    Meeting Abstract

    Wainberg, Z. A.; Manji, G. A.; Bahary, N.; Ulahannan, S. V.; Pant, S.; Uboha, N. V.; Oberstein, P. E.; Lu, L. H.; Scott, J. R.; Wu, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma
    Meeting Abstract

    Nasar, N.; Armstrong, M.; Chou, J. F.; Gonen, M.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Wei, A. C. C.; D'Angelica, M. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-derived biliary tract cancer organoid biobank: Is personalized medicine utilizing organoids feasible for patients with cholangiocarcinoma?
    Meeting Abstract

    Nasar, N.; McIntyre, S. M. H.; Kalvin, H. L.; Gonen, M.; Lecomte, N.; Karnoub, E.; Hong, J.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomical location and outcome
    Meeting Abstract

    Preston, W. A.; Drill, E. N.; Boerner, T.; Harding, J. J.; Cercek, A.; O'Reilly, E. M.; Abou-Alfa, G. K.; Park, W.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save